Running Gene
Latest round
- Series B
Last raised
- May 2017
Total raised
- $3M
Investors
- 4
About Running Gene
Based in Beijing, China and established in 2013, Running Gene Inc. is a biotechnology company that focuses on gene diagnoses series. The company has developed an intelligent interpretation system for genetic diseases, the "Mingjian System", which collects genetic samples, extracts and processes DNA, and then sequences and analyzes the data. It also focuses on the areas of reproductive health and tumor prevention and treatment, integrating big data such as genes, proteins and metabolic small molecules with clinical resources and scientific research projects for screening and diagnosis of clinically relevant diseases as well as precise application of treatment plans.
Who invested in Running Gene
4 investors across 3 rounds
See all investors in Running Gene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Running Gene
Who invested in Running Gene?
Running Gene has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Running Gene raised?
Running Gene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Running Gene last raise money?
Running Gene's most recent round on record is a Series B, in May 2017.
What does Running Gene do?
Based in Beijing, China and established in 2013, Running Gene Inc.
Where is Running Gene headquartered?
Running Gene is headquartered in Beijing, China.
Which VCs invest in companies like Running Gene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Running Gene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Running Gene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.